Skip to content
Medical Health Aged Care

ONE WEEK TO GO until Canberra’s Memory Walk & Jog!

Dementia Australia 2 mins read

With only a few sleeps to go walkers, joggers and runners are gearing up to participate in the 2024 Canberra Memory Walk & Jog.

More than 700 people have already signed-up to take part – but there’s always room for more with online registrations still open, or sign-up on the day of the event.  

Dementia Australia CEO Maree McCabe AM said it is fantastic to see Canberra locals throwing their support behind Memory Walk & Jog.

“As we prepare to host Memory Walk & Jog on Sunday 25 March at Lake Burley Griffin for another successful year, we hope everyone will consider joining us,” Ms McCabe said.

“It’s estimated that 65 per cent of people living with dementia live in the community. This could be a family member, a friend or a neighbour. It could be anyone in our community. By walking, jogging, or running, raising money and awareness, you will help the countless families impacted by dementia in Canberra and across Australia.”

 

This event is one of 22 Memory Walk & Jog events which will be held across Australia in 2024. Participants can register as an individual or an entire team, to remember a loved one, or in support of a loved one who is currently living with dementia. Each event offers a wonderful opportunity for people impacted by dementia and their supporters to come together, walk or run, at any fitness level, and to raise money and share stories.   

Walk or jog with us. We are in this together. 

 

Sign-up to walk, jog or run or join in as a Volunteer at www.memorywalk.com.au. Share your Memory Walk & Jog experience on your socials and Donate today to support people living with dementia across Australia. 

 

If you can’t attend an event, why not organise your own group or individual walk or jog, with a MyWay event. Choose your own date and location and register at www.memorywalk.com.au/get-involved/mw.

 

Dementia Australia spokespeople and a local case study are available for media stories. Please contact Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, [email protected]

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.  

 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au   

 

-Ends-

Media contacts: Ash Blakemore, Senior Media & Communications Advisor, 0448 170 672, [email protected]. Andrea Hogan, Media and Communications Manager, 0406 904 118, [email protected]

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

Media

More from this category

  • Medical Health Aged Care
  • 13/05/2025
  • 12:10
EnGeneIC

EnGeneIC launches groundbreaking new Australian trial for innovative cancer therapy, with international trial site in Singapore to follow

First Patient dosed in Phase I/IIa Basket Trial for Solid Tumours at Mater Hospital, North SydneyRecruitment to open this month at Frankston Hospital, VictoriaFurther site to follow at Curie Oncology, SingaporeSYDNEY, May 12, 2025 (GLOBE NEWSWIRE) -- EnGeneIC Pty Ltd, a Sydney-based biotechnology company and leader in innovative cancer therapies, has announced the successful dosing of the first patient in its open-label, multicentre, Phase I/IIa clinical trial at Mater Hospital, Sydney. The trial (ENG19) is an essential next step in progressing EnGeneIC’s novel platform technology through the clinic and to market. It will assess the safety and efficacy of EGFR-targeted…

  • Medical Health Aged Care
  • 13/05/2025
  • 11:36
Dementia Australia

Templestowe show their support for people impacted by dementia

Templestowe community members turned up in force last weekend, showing their support for people impacted by dementia whilst getting active to improve their brain health. Participating in the 2025 Memory Walk & Jog at Westerfolds Park more than 290 people walked, ran and jogged to raise an impressive total of $30,000. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, raised funds, spread the word and donated. “There was an outstanding show of support from the Templestowe community who turned out in such large numbers for the first time in support of people impacted by dementia,”…

  • Contains:
  • Medical Health Aged Care
  • 13/05/2025
  • 11:16
Dementia Australia

South East Melbourne show their support for people impacted by dementia

South East Melbourne community members turned up in force last weekend, showing their support for people impacted by dementia whilst getting active to improve their brain health. Participating in the 2025 Memory Walk & Jog at Peter Scullin Reserve, Mordialloc, more than 325 people walked, ran and jogged to raise an impressive total of $40,000. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, raised funds, spread the word and donated. “There was an outstanding show of support from the South East Melbourne community who turned out in such large numbers for the first time in…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.